Recent Finacing
Recent Raise
Lysogene is a biotech company developing intracerebral gene therapies for CNS lysosomal storage and neurodegenerative disorders, with clinical-stage programs for Sanfilippo syndrome type A and GM1 gangliosidosis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at LYSOGENE.